These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7272932)

  • 1. Clinical pharmacology of tamoxifen in patients with breast cancer: correlation with clinical data.
    Fabian C; Sternson L; El-Serafi M; Cain L; Hearne E
    Cancer; 1981 Aug; 48(4):876-82. PubMed ID: 7272932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of tamoxifen in patients with breast cancer: comparison of traditional and loading dose schedules.
    Fabian C; Sternson L; Barnett M
    Cancer Treat Rep; 1980; 64(6-7):765-73. PubMed ID: 7427961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and urine levels of tamoxifen and its metabolites in patients with advanced breast cancer after a loading dose and at steady-state levels.
    de Vos D; Slee PH; Briggs RJ; Stevenson D
    Cancer Chemother Pharmacol; 1998; 42(6):512-4. PubMed ID: 9788580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The steady-state pharmacokinetics of tamoxifen and its metabolites in breast cancer patients.
    Soininen K; Kleimola T; Elomaa I; Salmo M; Rissanen P
    J Int Med Res; 1986; 14(3):162-5. PubMed ID: 3522312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I trial and pharmacokinetic study of tipifarnib, a farnesyltransferase inhibitor, and tamoxifen in metastatic breast cancer.
    Lebowitz PF; Eng-Wong J; Widemann BC; Balis FM; Jayaprakash N; Chow C; Clark G; Gantz SB; Venzon D; Zujewski J
    Clin Cancer Res; 2005 Feb; 11(3):1247-52. PubMed ID: 15709195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicentre trial to compare a loading dose regimen of tamoxifen ('Nolvadex') with conventional dosing in the treatment of advanced breast cancer. The British Tamoxifen Study Group.
    Spooner D; Fairlamb D; Fermont D
    Clin Oncol (R Coll Radiol); 1991 May; 3(3):133-6. PubMed ID: 2069877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idoxifene: report of a phase I study in patients with metastatic breast cancer.
    Coombes RC; Haynes BP; Dowsett M; Quigley M; English J; Judson IR; Griggs LJ; Potter GA; McCague R; Jarman M
    Cancer Res; 1995 Mar; 55(5):1070-4. PubMed ID: 7866990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer.
    Budd GT; Adamson PC; Gupta M; Homayoun P; Sandstrom SK; Murphy RF; McLain D; Tuason L; Peereboom D; Bukowski RM; Ganapathi R
    Clin Cancer Res; 1998 Mar; 4(3):635-42. PubMed ID: 9533531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters.
    Morgan LR; Schein PS; Woolley PV; Hoth D; Macdonald J; Lippman M; Posey LE; Beazley RW
    Cancer Treat Rep; 1976 Oct; 60(10):1437-43. PubMed ID: 191185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen (Nolvadex) therapy--radionale for loading dose followed by maintenance dose for patients with metastatic breast cancer.
    Wilkinson PM; Ribiero GG; Adam HK; Kemp JV; Patterson JS
    Cancer Chemother Pharmacol; 1982 Dec; 10(1):33-5. PubMed ID: 7160042
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancer.
    Ingle JN; Everson LK; Wieand HS; Cullinan SA; Wold LE; Hagen JB; Martin JK; Krook JE; Fitzgibbons RG; Foley JF
    Cancer; 1989 Apr; 63(7):1257-64. PubMed ID: 2646004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence of 20-mg once-daily tamoxifen relative to 10-mg twice-daily tamoxifen regimens for breast cancer.
    Buzdar AU; Hortobagyi GN; Frye D; Ho D; Booser DJ; Valero V; Holmes FA; Birmingham BK; Bui K; Yeh C
    J Clin Oncol; 1994 Jan; 12(1):50-4. PubMed ID: 8270984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of tamoxifen doses with and without fluoxymesterone in advanced breast cancer.
    Tormey DC; Lippman ME; Edwards BK; Cassidy JG
    Ann Intern Med; 1983 Feb; 98(2):139-44. PubMed ID: 6824247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluations.
    Lawrence JA; Adamson PC; Caruso R; Chow C; Kleiner D; Murphy RF; Venzon DJ; Shovlin M; Noone M; Merino M; Cowan KH; Kaiser M; O'Shaughnessy J; Zujewski J
    J Clin Oncol; 2001 May; 19(10):2754-63. PubMed ID: 11352969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I/II trial of continuous infusion vinorelbine for advanced breast cancer.
    Toussaint C; Izzo J; Spielmann M; Merle S; May-Levin F; Armand JP; Lacombe D; Tursz T; Sunderland M; Chabot GG
    J Clin Oncol; 1994 Oct; 12(10):2102-12. PubMed ID: 7931480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of tamoxifen dose in advanced breast cancer: a progress report.
    Tormey DC; Simon RM; Lippman ME; Bull JM; Myers CE
    Cancer Treat Rep; 1976 Oct; 60(10):1451-9. PubMed ID: 1021226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen-induced remission in breast cancer by escalating the dose to 40 mg daily after progression on 20 mg daily: a case report and review of the literature.
    Manni A; Arafah BM
    Cancer; 1981 Aug; 48(4):873-5. PubMed ID: 7272931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of tamoxifen: report of 74 patients with stage IV breast cancer.
    Lerner HJ; Band PR; Israel L; Leung BS
    Cancer Treat Rep; 1976 Oct; 60(10):1431-5. PubMed ID: 798626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Steady state and disappearance of the metabolites of miproxifene phosphate in the treatment of breast cancer].
    Morimoto K; Abe O; Kinoshita H
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1565-73. PubMed ID: 9725050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weekly docetaxel/paclitaxel in pretreated metastatic breast cancer.
    Gennari A; Guarneri V; Landucci E; Orlandini C; Rondini M; Salvadori B; Ricci S; Conte PF
    Clin Breast Cancer; 2002 Dec; 3(5):346-52. PubMed ID: 12533265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.